Loading...
Guest User
Welcome! Please login.
| IPO Listing At | BSE, NSE |
| IPO Issue Type | Book Build Issue |
| Issue Size | ₹200.41 Cr |
| Fresh Issue | ₹160.46 Cr |
| Offer for Sale | ₹39.95 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹105.00-111.00 per share |
| Discount | Employee: 11.00 |
| BSE Code | 544432 |
| NSE Code | IGCL |
| Registrar | Bigshare Services Pvt.Ltd. |
| Lead Managers | Systematix Corporate Services Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 135 shares and in multiples thereof
Incorporated in 1993, Indogulf Cropsciences Limited is engaged in manufacturing crop protection products, plant nutrients, and biologicals in India.
The company manufactured Spiromesifen technical with 96.5% purity in 2019 and is one of the first indigenous manufacturers of Pyrazosulfuron Ethyl technical with 97% purity in India.
The company operates four manufacturing facilities in Samba (Jammu & Kashmir) and Nathupur (Haryana), covering approximately twenty acres, including two sites in Nathupur and one in Barwasni, Haryana.
The company has a sales network across 22 states and 3 Union Territories in India, with 169 business partners, 5,772 distributors, and 129 partners in 34 countries worldwide.
The company’s flexible, multi-purpose facilities allow diverse product manufacturing, adapting to customer needs. Its competitive advantage is strengthened by high regulatory barriers in the agrochemical industry, including costs and complex approvals.
Product Portfolio:
As of August 31, 2024, the company had 640 permanent employees.
Competitive Strengths:
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding working capital requirements of the Company | 65.00 |
| 2 | Repayment/ prepayment, in full or in part, of certain outstanding borrowings availed by the Company | 34.12 |
| 3 | Capital expenditure of the Company for setting up an in-house dry flowable (DF) plant at Barwasni, District Sonipat, Haryana | 14.00 |
| 4 | General Corporate Purposes | 27.85 |
| 5 | Issue Expenses | 23.78 |
| Total | 164.74 |
| Period Ended | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 597.81 | 542.25 | 517.51 | 413.59 |
| Total Income | 466.31 | 555.79 | 552.19 | 490.23 |
| Profit After Tax | 21.68 | 28.23 | 22.42 | 26.36 |
| EBITDA | 44.78 | 55.74 | 49.04 | 47.24 |
| NET Worth | 265.43 | 231.65 | 203.25 | 180.51 |
| Reserves and Surplus | 216.64 | 208.01 | 179.60 | 156.87 |
| Total Borrowing | 206.30 | 154.56 | 189.22 | 101.38 |
| Amount in ₹ Crore | ||||
| KPI | Mar 31, 2024 |
|---|---|
| ROE | 12.2% |
| ROCE | 11.93% |
| Debt / Equity | 0.67% |
| RoNW | 12.19% |
| PAT Margin | 5.11% |
| EBITDA Margin | 10.09% |
| Price to Book Value | 1.13 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 5.79 | 4.57 |
| P/E (x) | 19.18 | 24.27 |
| Promoter Holding | 96.86% | 68% |
| Market Cap | ₹701.54 Cr. | |
